• recombinant
  • We have previously shown that within tumors, recombinant interleukin-2 (rIL-2, aldesleukin) consistently activates tumor-associated macrophages and upregulates IFN-stimulated genes while inducing minimal migration, activation, or proliferation of T cells. (aacrjournals.org)
  • health
  • Some of the "Schedule F Recommended" entries may have been added or will shortly be added to the PDL by Health Canada, but either way these entries will continue to be listed in Schedule I of the NDS. (napra.ca)
  • For more information on the Prescription Drug List, please consult the Health Canada website . (napra.ca)
  • patients
  • It is important for patients to remember that physicians have the ability to prescribe medication for conditions other than those for which the drug has been approved by the FDA. (unm.edu)
  • Patients will usually have scheduled meetings with their healthcare provider while they are being treated with aldesleukin. (unm.edu)
  • Patients may wish to discuss with their physician the other less common side effects of this drug, some of which may be serious. (unm.edu)